Skip to main content

Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation.

Publication ,  Journal Article
Joo, JH; Hong, S; Rybicki, LA; Hamilton, BK; Majhail, NS
Published in: Bone Marrow Transplant
April 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Bone Marrow Transplant

DOI

EISSN

1476-5365

Publication Date

April 2022

Volume

57

Issue

4

Start / End Page

671 / 673

Location

England

Related Subject Headings

  • Transplantation, Autologous
  • Survivors
  • Public Health
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Joo, J. H., Hong, S., Rybicki, L. A., Hamilton, B. K., & Majhail, N. S. (2022). Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant, 57(4), 671–673. https://doi.org/10.1038/s41409-022-01602-z
Joo, Julia H., Sanghee Hong, Lisa A. Rybicki, Betty K. Hamilton, and Navneet S. Majhail. “Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation.Bone Marrow Transplant 57, no. 4 (April 2022): 671–73. https://doi.org/10.1038/s41409-022-01602-z.
Joo JH, Hong S, Rybicki LA, Hamilton BK, Majhail NS. Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2022 Apr;57(4):671–3.
Joo, Julia H., et al. “Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation.Bone Marrow Transplant, vol. 57, no. 4, Apr. 2022, pp. 671–73. Pubmed, doi:10.1038/s41409-022-01602-z.
Joo JH, Hong S, Rybicki LA, Hamilton BK, Majhail NS. Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2022 Apr;57(4):671–673.

Published In

Bone Marrow Transplant

DOI

EISSN

1476-5365

Publication Date

April 2022

Volume

57

Issue

4

Start / End Page

671 / 673

Location

England

Related Subject Headings

  • Transplantation, Autologous
  • Survivors
  • Public Health
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences